Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in China
中国全国登记研究:表皮生长因子受体(EGFR)突变型晚期非小细胞肺癌接受EGFR酪氨酸激酶抑制剂(TKI)治疗的预后因素
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-275
Liang, Wenhua; Chen, Peiling; Li, Jianfu; Fu, Wenhai; Zheng, Xin; Diao, Jingwen; Wang, Ning; Feng, Xuefei; Zhong, Ran; Yu, Ziwen; Li, Chunyan; Wang, Haixuan; Cheng, Bo; Li, Caichen; Xiong, Shan; Li, Feng; Jiang, Yu; Lin, Yuechun; Wang, Runchen; Zhang, Tiantian; Wang, Baohua; Wu, Jing; Zhong, Nanshan; He, Jianxing